fbpx
August 10, 2020

Candesartan May Improve Cognition Independent of Blood Pressure Candesartan May Improve Cognition Independent of Blood Pressure

The angiotensin receptor blocker (ARB) candesartan is associated with superior neurocognitive outcomes compared with lisinopril in older adults with hypertension and mild cognitive impairment, a new […]
August 10, 2020

FDA Approves IV Opioid Oliceridine for Short-term Use FDA Approves IV Opioid Oliceridine for Short-term Use

The US Food and Drug Administration (FDA) has approved the intravenous (IV) opioid oliceridine (Olinvyk) for the management of moderate to severe acute pain in adults […]
August 7, 2020

FDA OKs First Oral Treatment for Spinal Muscular Atrophy FDA OKs First Oral Treatment for Spinal Muscular Atrophy

The US Food and Drug Administration (FDA) has approved risdiplam (Evrysdi, Roche and PTC Therapeutics) for the treatment of adults and children at least 2 months […]
August 7, 2020

Vitamin D May Reduce Recurrence of Positional Vertigo Vitamin D May Reduce Recurrence of Positional Vertigo

Daily supplementation with vitamin D and calcium carbonate significantly reduced recurrence of benign paroxysmal positional vertigo (BPPV), especially in patients with low serum vitamin D, results […]
August 6, 2020

Ofatumumab Phase 3 Multiple Sclerosis Trials Published Ofatumumab Phase 3 Multiple Sclerosis Trials Published

Two phase 3 clinical trials showing impressive results with the new subcutaneously-delivered, B-cell depleting multiple sclerosis anti-CD20 mononclonal antibody ofatumumab (Arzerra) have now been published in […]
August 5, 2020

High BMI in Early Adulthood Linked to Increased Dementia Risk High BMI in Early Adulthood Linked to Increased Dementia Risk

Higher body mass index (BMI) in early adulthood is associated with an increased risk for dementia later in life, new research suggests. The study is the […]
August 3, 2020

FDA Approves Cannabidiol for Tuberous Sclerosis Complex FDA Approves Cannabidiol for Tuberous Sclerosis Complex

The cannabidiol (CBD) oral solution Epidiolex has been approved by the US Food and Drug Administration (FDA) for the new indication of treatment of seizures associated […]
August 3, 2020

In Epilepsy, Brain-Responsive Stimulation Passes Long-term Tests In Epilepsy, Brain-Responsive Stimulation Passes Long-term Tests

Two new long-term studies, one an extension trial and the other an analysis of real-world experience, show that the RNS System direct brain responsive neurostimulator leads […]
August 3, 2020

Delayed Driving Reactions Even After Concussion Symptoms Resolve Delayed Driving Reactions Even After Concussion Symptoms Resolve

Individuals who have experienced a concussion may not be ready to drive even after symptoms have resolved, new research from a small study suggests.  A small […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0